Renibus Therapeutics
TX - Southlake
BiotechnologyFocus: Small Molecules
Renibus Therapeutics is a life sciences company focused on Small Molecules.
Infectious DiseasesNephrology
Funding Stage
PUBLIC
Employees
51-200
Open Jobs
0
Pipeline & Clinical Trials
Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG)
Post-discharge OutcomesClinical Trials (1)
NCT07009340Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery
N/AClinical Trials (1)
NCT06092970An Evaluation of Patient Reported Outcomes and Clinical Outcomes
N/AFeS and SnPP
Acute Kidney InjuryClinical Trials (1)
NCT03630029RBT-1 Phase 1b Clinical Trial in Healthy Volunteers and Subjects With CKD
Phase 1RBT-1
Healthy VolunteersClinical Trials (1)
NCT03893799A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease
Phase 1RBT-9
Healthy VolunteersClinical Trials (1)
NCT04072861A Study of RBT-9 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease
Phase 1RBT-3
Healthy VolunteersClinical Trials (1)
NCT04072432A Study of RBT-3 in Healthy Volunteers and Volunteers With Stage 3/4 Chronic Kidney Disease
Phase 1Low Dose RBT-1
AKIClinical Trials (1)
NCT04564833Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery
Phase 2RBT-9
COVID-19Clinical Trials (1)
NCT04364763A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study)
Phase 2Veverimer
CKDClinical Trials (1)
NCT07355062A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Phase 3Phase 3
Clinical Trials (1)
NCT06021457Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2023
Portfolio: 10 clinical trials